Key result
Applying NCEP ATP III criteria instead of ATP II criteria to patients on statin therapy resulted in a 6.8% decrease in LDL-C goal attainment.
Why the study?
Does applying NCEP ATP III criteria compared to ATP II criteria reduce the rate of LDL-C goal attainment in managed care enrollees on statin therapy?
Observational (n=1,962)
Does applying NCEP ATP III criteria compared to ATP II criteria reduce the rate of LDL-C goal attainment in managed care enrollees on statin therapy?
The application of the more stringent NCEP ATP III guidelines significantly decreases the proportion of statin-treated patients achieving their LDL-C goals, highlighting the need for intensified lipid-lowering therapy.
Answers are grounded in this paper and cite their sources.
ATP III criteria were associated with lower LDL-C goal attainment in statin users; hypothesis-generating for intensified therapy needs in managed care.
OBJECTIVE: Revised treatment goals suggested by the third report of the National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP III) represent a challenge to both physicians and the health care industry. We sought to quantify the impact of these changes in a large managed care population being treated with statin therapy. METHODS: Using data collected from a retrospective chart review of 1,962 managed care enrollees who received statin drug therapy between February 2001 and August 2001, we quantified the low-density lipoprotein cholesterol (LDL-C) goals and goal attainment of this population according to both the NCEP ATP II and ATP III criteria and further identified independent predictors of ATP III goal attainment using multivariable logistic regression modeling. RESULTS: Overall, 21.1% (n = 414) of statin patients moved to a more stringent LDL-C goal when ATP III criteria were applied over ATP II. Substituting ATP III criteria for ATP II criteria resulted in a 6.8% decrease in the percentage of participants who had their most recent LDL-C value below the suggested goal, from 59.8% under ATP II to 53.0% under ATP III. Persons with existing coronary heart disease, diabetes, obesity, and stroke or transient ischemic attack were all less likely to meet the suggested NCEP ATP III LDL-C goal. CONCLUSION: Taking into account the revised risk stratification of the ATP III guidelines and the lack of LDL-C goal attainment in patients currently taking statins, there will be an increase in the number of statin patients who require dose or agent adjustment, combination therapy, or compliance counseling to achieve their lower LDL-C goal.
No takes yet. Share an insight, caveat, or question.
Quilliam et al. (2004) conducted an observational in Patients treated with statin therapy (n=1,962). NCEP ATP III criteria vs. NCEP ATP II criteria was evaluated on Percentage of participants with most recent LDL-C value below the suggested goal. Applying NCEP ATP III criteria instead of ATP II criteria to patients on statin therapy resulted in a 6.8% decrease in LDL-C goal attainment.
Synapse has enriched 10 related papers. Consider them for comparative context: